0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Dihydrocodeine Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-23A7994
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Dihydrocodeine Market Insights Forecast to 2028
BUY CHAPTERS

Global Dihydrocodeine Market Research Report 2025

Code: QYRE-Auto-23A7994
Report
July 2025
Pages:98
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Dihydrocodeine Market Size

The global market for Dihydrocodeine was valued at US$ 2774 million in the year 2024 and is projected to reach a revised size of US$ 3885 million by 2031, growing at a CAGR of 5.0% during the forecast period.

Dihydrocodeine Market

Dihydrocodeine Market

Dihydrocodeine is a semi-synthetic opioid analgesic prescribed for pain or severe dyspnea, or as an antitussive, either alone or compounded with paracetamol (acetaminophen) (as in co-dydramol) or aspirin.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dihydrocodeine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dihydrocodeine.
The Dihydrocodeine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dihydrocodeine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dihydrocodeine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Dihydrocodeine Market Report

Report Metric Details
Report Name Dihydrocodeine Market
Accounted market size in year US$ 2774 million
Forecasted market size in 2031 US$ 3885 million
CAGR 5.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AHPL, Teofarma, Mundipharma, Napp Pharmaceuticals, Aspen Pharmacare, Martindale-Hubbell, Duopharma Biotech Berhad, Wockhardt, Auden Mckenzie Pharma, WraSer, GlaxoSmithKline, G.L. Pharma, Daiichi Sankyo, Fuso Pharmaceutical, Nichi-Iko Pharmaceutical, Takata Pharmaceutical, Toyo Seikan Group, Teva
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Dihydrocodeine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Dihydrocodeine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Dihydrocodeine Market growing?

Ans: The Dihydrocodeine Market witnessing a CAGR of 5.0% during the forecast period 2025-2031.

What is the Dihydrocodeine Market size in 2031?

Ans: The Dihydrocodeine Market size in 2031 will be US$ 3885 million.

Who are the main players in the Dihydrocodeine Market report?

Ans: The main players in the Dihydrocodeine Market are AHPL, Teofarma, Mundipharma, Napp Pharmaceuticals, Aspen Pharmacare, Martindale-Hubbell, Duopharma Biotech Berhad, Wockhardt, Auden Mckenzie Pharma, WraSer, GlaxoSmithKline, G.L. Pharma, Daiichi Sankyo, Fuso Pharmaceutical, Nichi-Iko Pharmaceutical, Takata Pharmaceutical, Toyo Seikan Group, Teva

What are the Application segmentation covered in the Dihydrocodeine Market report?

Ans: The Applications covered in the Dihydrocodeine Market report are Cough Suppressant, Analgesic

What are the Type segmentation covered in the Dihydrocodeine Market report?

Ans: The Types covered in the Dihydrocodeine Market report are Oral, Injection

Recommended Reports

Pain Management Drugs

Opioids & Analgesics

Cough & API Markets

1 Dihydrocodeine Market Overview
1.1 Product Definition
1.2 Dihydrocodeine by Type
1.2.1 Global Dihydrocodeine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Oral
1.2.3 Injection
1.3 Dihydrocodeine by Application
1.3.1 Global Dihydrocodeine Market Value by Application (2024 VS 2031)
1.3.2 Cough Suppressant
1.3.3 Analgesic
1.4 Global Dihydrocodeine Market Size Estimates and Forecasts
1.4.1 Global Dihydrocodeine Revenue 2020-2031
1.4.2 Global Dihydrocodeine Sales 2020-2031
1.4.3 Global Dihydrocodeine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Dihydrocodeine Market Competition by Manufacturers
2.1 Global Dihydrocodeine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Dihydrocodeine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Dihydrocodeine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Dihydrocodeine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Dihydrocodeine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dihydrocodeine, Product Type & Application
2.7 Global Key Manufacturers of Dihydrocodeine, Date of Enter into This Industry
2.8 Global Dihydrocodeine Market Competitive Situation and Trends
2.8.1 Global Dihydrocodeine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Dihydrocodeine Players Market Share by Revenue
2.8.3 Global Dihydrocodeine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Dihydrocodeine Market Scenario by Region
3.1 Global Dihydrocodeine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Dihydrocodeine Sales by Region: 2020-2031
3.2.1 Global Dihydrocodeine Sales by Region: 2020-2025
3.2.2 Global Dihydrocodeine Sales by Region: 2026-2031
3.3 Global Dihydrocodeine Revenue by Region: 2020-2031
3.3.1 Global Dihydrocodeine Revenue by Region: 2020-2025
3.3.2 Global Dihydrocodeine Revenue by Region: 2026-2031
3.4 North America Dihydrocodeine Market Facts & Figures by Country
3.4.1 North America Dihydrocodeine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Dihydrocodeine Sales by Country (2020-2031)
3.4.3 North America Dihydrocodeine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Dihydrocodeine Market Facts & Figures by Country
3.5.1 Europe Dihydrocodeine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Dihydrocodeine Sales by Country (2020-2031)
3.5.3 Europe Dihydrocodeine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dihydrocodeine Market Facts & Figures by Region
3.6.1 Asia Pacific Dihydrocodeine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Dihydrocodeine Sales by Region (2020-2031)
3.6.3 Asia Pacific Dihydrocodeine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Dihydrocodeine Market Facts & Figures by Country
3.7.1 Latin America Dihydrocodeine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Dihydrocodeine Sales by Country (2020-2031)
3.7.3 Latin America Dihydrocodeine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dihydrocodeine Market Facts & Figures by Country
3.8.1 Middle East and Africa Dihydrocodeine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Dihydrocodeine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Dihydrocodeine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dihydrocodeine Sales by Type (2020-2031)
4.1.1 Global Dihydrocodeine Sales by Type (2020-2025)
4.1.2 Global Dihydrocodeine Sales by Type (2026-2031)
4.1.3 Global Dihydrocodeine Sales Market Share by Type (2020-2031)
4.2 Global Dihydrocodeine Revenue by Type (2020-2031)
4.2.1 Global Dihydrocodeine Revenue by Type (2020-2025)
4.2.2 Global Dihydrocodeine Revenue by Type (2026-2031)
4.2.3 Global Dihydrocodeine Revenue Market Share by Type (2020-2031)
4.3 Global Dihydrocodeine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Dihydrocodeine Sales by Application (2020-2031)
5.1.1 Global Dihydrocodeine Sales by Application (2020-2025)
5.1.2 Global Dihydrocodeine Sales by Application (2026-2031)
5.1.3 Global Dihydrocodeine Sales Market Share by Application (2020-2031)
5.2 Global Dihydrocodeine Revenue by Application (2020-2031)
5.2.1 Global Dihydrocodeine Revenue by Application (2020-2025)
5.2.2 Global Dihydrocodeine Revenue by Application (2026-2031)
5.2.3 Global Dihydrocodeine Revenue Market Share by Application (2020-2031)
5.3 Global Dihydrocodeine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AHPL
6.1.1 AHPL Company Information
6.1.2 AHPL Description and Business Overview
6.1.3 AHPL Dihydrocodeine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AHPL Dihydrocodeine Product Portfolio
6.1.5 AHPL Recent Developments/Updates
6.2 Teofarma
6.2.1 Teofarma Company Information
6.2.2 Teofarma Description and Business Overview
6.2.3 Teofarma Dihydrocodeine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Teofarma Dihydrocodeine Product Portfolio
6.2.5 Teofarma Recent Developments/Updates
6.3 Mundipharma
6.3.1 Mundipharma Company Information
6.3.2 Mundipharma Description and Business Overview
6.3.3 Mundipharma Dihydrocodeine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Mundipharma Dihydrocodeine Product Portfolio
6.3.5 Mundipharma Recent Developments/Updates
6.4 Napp Pharmaceuticals
6.4.1 Napp Pharmaceuticals Company Information
6.4.2 Napp Pharmaceuticals Description and Business Overview
6.4.3 Napp Pharmaceuticals Dihydrocodeine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Napp Pharmaceuticals Dihydrocodeine Product Portfolio
6.4.5 Napp Pharmaceuticals Recent Developments/Updates
6.5 Aspen Pharmacare
6.5.1 Aspen Pharmacare Company Information
6.5.2 Aspen Pharmacare Description and Business Overview
6.5.3 Aspen Pharmacare Dihydrocodeine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Aspen Pharmacare Dihydrocodeine Product Portfolio
6.5.5 Aspen Pharmacare Recent Developments/Updates
6.6 Martindale-Hubbell
6.6.1 Martindale-Hubbell Company Information
6.6.2 Martindale-Hubbell Description and Business Overview
6.6.3 Martindale-Hubbell Dihydrocodeine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Martindale-Hubbell Dihydrocodeine Product Portfolio
6.6.5 Martindale-Hubbell Recent Developments/Updates
6.7 Duopharma Biotech Berhad
6.7.1 Duopharma Biotech Berhad Company Information
6.7.2 Duopharma Biotech Berhad Description and Business Overview
6.7.3 Duopharma Biotech Berhad Dihydrocodeine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Duopharma Biotech Berhad Dihydrocodeine Product Portfolio
6.7.5 Duopharma Biotech Berhad Recent Developments/Updates
6.8 Wockhardt
6.8.1 Wockhardt Company Information
6.8.2 Wockhardt Description and Business Overview
6.8.3 Wockhardt Dihydrocodeine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Wockhardt Dihydrocodeine Product Portfolio
6.8.5 Wockhardt Recent Developments/Updates
6.9 Auden Mckenzie Pharma
6.9.1 Auden Mckenzie Pharma Company Information
6.9.2 Auden Mckenzie Pharma Description and Business Overview
6.9.3 Auden Mckenzie Pharma Dihydrocodeine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Auden Mckenzie Pharma Dihydrocodeine Product Portfolio
6.9.5 Auden Mckenzie Pharma Recent Developments/Updates
6.10 WraSer
6.10.1 WraSer Company Information
6.10.2 WraSer Description and Business Overview
6.10.3 WraSer Dihydrocodeine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 WraSer Dihydrocodeine Product Portfolio
6.10.5 WraSer Recent Developments/Updates
6.11 GlaxoSmithKline
6.11.1 GlaxoSmithKline Company Information
6.11.2 GlaxoSmithKline Description and Business Overview
6.11.3 GlaxoSmithKline Dihydrocodeine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 GlaxoSmithKline Dihydrocodeine Product Portfolio
6.11.5 GlaxoSmithKline Recent Developments/Updates
6.12 G.L. Pharma
6.12.1 G.L. Pharma Company Information
6.12.2 G.L. Pharma Description and Business Overview
6.12.3 G.L. Pharma Dihydrocodeine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 G.L. Pharma Dihydrocodeine Product Portfolio
6.12.5 G.L. Pharma Recent Developments/Updates
6.13 Daiichi Sankyo
6.13.1 Daiichi Sankyo Company Information
6.13.2 Daiichi Sankyo Description and Business Overview
6.13.3 Daiichi Sankyo Dihydrocodeine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Daiichi Sankyo Dihydrocodeine Product Portfolio
6.13.5 Daiichi Sankyo Recent Developments/Updates
6.14 Fuso Pharmaceutical
6.14.1 Fuso Pharmaceutical Company Information
6.14.2 Fuso Pharmaceutical Description and Business Overview
6.14.3 Fuso Pharmaceutical Dihydrocodeine Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Fuso Pharmaceutical Dihydrocodeine Product Portfolio
6.14.5 Fuso Pharmaceutical Recent Developments/Updates
6.15 Nichi-Iko Pharmaceutical
6.15.1 Nichi-Iko Pharmaceutical Company Information
6.15.2 Nichi-Iko Pharmaceutical Description and Business Overview
6.15.3 Nichi-Iko Pharmaceutical Dihydrocodeine Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Nichi-Iko Pharmaceutical Dihydrocodeine Product Portfolio
6.15.5 Nichi-Iko Pharmaceutical Recent Developments/Updates
6.16 Takata Pharmaceutical
6.16.1 Takata Pharmaceutical Company Information
6.16.2 Takata Pharmaceutical Description and Business Overview
6.16.3 Takata Pharmaceutical Dihydrocodeine Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Takata Pharmaceutical Dihydrocodeine Product Portfolio
6.16.5 Takata Pharmaceutical Recent Developments/Updates
6.17 Toyo Seikan Group
6.17.1 Toyo Seikan Group Company Information
6.17.2 Toyo Seikan Group Description and Business Overview
6.17.3 Toyo Seikan Group Dihydrocodeine Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Toyo Seikan Group Dihydrocodeine Product Portfolio
6.17.5 Toyo Seikan Group Recent Developments/Updates
6.18 Teva
6.18.1 Teva Company Information
6.18.2 Teva Description and Business Overview
6.18.3 Teva Dihydrocodeine Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Teva Dihydrocodeine Product Portfolio
6.18.5 Teva Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dihydrocodeine Industry Chain Analysis
7.2 Dihydrocodeine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dihydrocodeine Production Mode & Process Analysis
7.4 Dihydrocodeine Sales and Marketing
7.4.1 Dihydrocodeine Sales Channels
7.4.2 Dihydrocodeine Distributors
7.5 Dihydrocodeine Customer Analysis
8 Dihydrocodeine Market Dynamics
8.1 Dihydrocodeine Industry Trends
8.2 Dihydrocodeine Market Drivers
8.3 Dihydrocodeine Market Challenges
8.4 Dihydrocodeine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Dihydrocodeine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Dihydrocodeine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Dihydrocodeine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Dihydrocodeine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Dihydrocodeine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Dihydrocodeine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Dihydrocodeine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Dihydrocodeine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Dihydrocodeine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Dihydrocodeine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Dihydrocodeine, Product Type & Application
 Table 12. Global Key Manufacturers of Dihydrocodeine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Dihydrocodeine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dihydrocodeine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Dihydrocodeine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Dihydrocodeine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Dihydrocodeine Sales Market Share by Region (2020-2025)
 Table 19. Global Dihydrocodeine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Dihydrocodeine Sales Market Share by Region (2026-2031)
 Table 21. Global Dihydrocodeine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Dihydrocodeine Revenue Market Share by Region (2020-2025)
 Table 23. Global Dihydrocodeine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Dihydrocodeine Revenue Market Share by Region (2026-2031)
 Table 25. North America Dihydrocodeine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Dihydrocodeine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Dihydrocodeine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Dihydrocodeine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Dihydrocodeine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Dihydrocodeine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Dihydrocodeine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Dihydrocodeine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Dihydrocodeine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Dihydrocodeine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Dihydrocodeine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Dihydrocodeine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Dihydrocodeine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Dihydrocodeine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Dihydrocodeine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Dihydrocodeine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Dihydrocodeine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Dihydrocodeine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Dihydrocodeine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Dihydrocodeine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Dihydrocodeine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Dihydrocodeine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Dihydrocodeine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Dihydrocodeine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Dihydrocodeine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Dihydrocodeine Sales (K Units) by Type (2020-2025)
 Table 51. Global Dihydrocodeine Sales (K Units) by Type (2026-2031)
 Table 52. Global Dihydrocodeine Sales Market Share by Type (2020-2025)
 Table 53. Global Dihydrocodeine Sales Market Share by Type (2026-2031)
 Table 54. Global Dihydrocodeine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Dihydrocodeine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Dihydrocodeine Revenue Market Share by Type (2020-2025)
 Table 57. Global Dihydrocodeine Revenue Market Share by Type (2026-2031)
 Table 58. Global Dihydrocodeine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Dihydrocodeine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Dihydrocodeine Sales (K Units) by Application (2020-2025)
 Table 61. Global Dihydrocodeine Sales (K Units) by Application (2026-2031)
 Table 62. Global Dihydrocodeine Sales Market Share by Application (2020-2025)
 Table 63. Global Dihydrocodeine Sales Market Share by Application (2026-2031)
 Table 64. Global Dihydrocodeine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Dihydrocodeine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Dihydrocodeine Revenue Market Share by Application (2020-2025)
 Table 67. Global Dihydrocodeine Revenue Market Share by Application (2026-2031)
 Table 68. Global Dihydrocodeine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Dihydrocodeine Price (US$/Unit) by Application (2026-2031)
 Table 70. AHPL Company Information
 Table 71. AHPL Description and Business Overview
 Table 72. AHPL Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. AHPL Dihydrocodeine Product
 Table 74. AHPL Recent Developments/Updates
 Table 75. Teofarma Company Information
 Table 76. Teofarma Description and Business Overview
 Table 77. Teofarma Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Teofarma Dihydrocodeine Product
 Table 79. Teofarma Recent Developments/Updates
 Table 80. Mundipharma Company Information
 Table 81. Mundipharma Description and Business Overview
 Table 82. Mundipharma Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Mundipharma Dihydrocodeine Product
 Table 84. Mundipharma Recent Developments/Updates
 Table 85. Napp Pharmaceuticals Company Information
 Table 86. Napp Pharmaceuticals Description and Business Overview
 Table 87. Napp Pharmaceuticals Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Napp Pharmaceuticals Dihydrocodeine Product
 Table 89. Napp Pharmaceuticals Recent Developments/Updates
 Table 90. Aspen Pharmacare Company Information
 Table 91. Aspen Pharmacare Description and Business Overview
 Table 92. Aspen Pharmacare Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Aspen Pharmacare Dihydrocodeine Product
 Table 94. Aspen Pharmacare Recent Developments/Updates
 Table 95. Martindale-Hubbell Company Information
 Table 96. Martindale-Hubbell Description and Business Overview
 Table 97. Martindale-Hubbell Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Martindale-Hubbell Dihydrocodeine Product
 Table 99. Martindale-Hubbell Recent Developments/Updates
 Table 100. Duopharma Biotech Berhad Company Information
 Table 101. Duopharma Biotech Berhad Description and Business Overview
 Table 102. Duopharma Biotech Berhad Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Duopharma Biotech Berhad Dihydrocodeine Product
 Table 104. Duopharma Biotech Berhad Recent Developments/Updates
 Table 105. Wockhardt Company Information
 Table 106. Wockhardt Description and Business Overview
 Table 107. Wockhardt Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Wockhardt Dihydrocodeine Product
 Table 109. Wockhardt Recent Developments/Updates
 Table 110. Auden Mckenzie Pharma Company Information
 Table 111. Auden Mckenzie Pharma Description and Business Overview
 Table 112. Auden Mckenzie Pharma Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Auden Mckenzie Pharma Dihydrocodeine Product
 Table 114. Auden Mckenzie Pharma Recent Developments/Updates
 Table 115. WraSer Company Information
 Table 116. WraSer Description and Business Overview
 Table 117. WraSer Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. WraSer Dihydrocodeine Product
 Table 119. WraSer Recent Developments/Updates
 Table 120. GlaxoSmithKline Company Information
 Table 121. GlaxoSmithKline Description and Business Overview
 Table 122. GlaxoSmithKline Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. GlaxoSmithKline Dihydrocodeine Product
 Table 124. GlaxoSmithKline Recent Developments/Updates
 Table 125. G.L. Pharma Company Information
 Table 126. G.L. Pharma Description and Business Overview
 Table 127. G.L. Pharma Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. G.L. Pharma Dihydrocodeine Product
 Table 129. G.L. Pharma Recent Developments/Updates
 Table 130. Daiichi Sankyo Company Information
 Table 131. Daiichi Sankyo Description and Business Overview
 Table 132. Daiichi Sankyo Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Daiichi Sankyo Dihydrocodeine Product
 Table 134. Daiichi Sankyo Recent Developments/Updates
 Table 135. Fuso Pharmaceutical Company Information
 Table 136. Fuso Pharmaceutical Description and Business Overview
 Table 137. Fuso Pharmaceutical Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Fuso Pharmaceutical Dihydrocodeine Product
 Table 139. Fuso Pharmaceutical Recent Developments/Updates
 Table 140. Nichi-Iko Pharmaceutical Company Information
 Table 141. Nichi-Iko Pharmaceutical Description and Business Overview
 Table 142. Nichi-Iko Pharmaceutical Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Nichi-Iko Pharmaceutical Dihydrocodeine Product
 Table 144. Nichi-Iko Pharmaceutical Recent Developments/Updates
 Table 145. Takata Pharmaceutical Company Information
 Table 146. Takata Pharmaceutical Description and Business Overview
 Table 147. Takata Pharmaceutical Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Takata Pharmaceutical Dihydrocodeine Product
 Table 149. Takata Pharmaceutical Recent Developments/Updates
 Table 150. Toyo Seikan Group Company Information
 Table 151. Toyo Seikan Group Description and Business Overview
 Table 152. Toyo Seikan Group Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Toyo Seikan Group Dihydrocodeine Product
 Table 154. Toyo Seikan Group Recent Developments/Updates
 Table 155. Teva Company Information
 Table 156. Teva Description and Business Overview
 Table 157. Teva Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Teva Dihydrocodeine Product
 Table 159. Teva Recent Developments/Updates
 Table 160. Key Raw Materials Lists
 Table 161. Raw Materials Key Suppliers Lists
 Table 162. Dihydrocodeine Distributors List
 Table 163. Dihydrocodeine Customers List
 Table 164. Dihydrocodeine Market Trends
 Table 165. Dihydrocodeine Market Drivers
 Table 166. Dihydrocodeine Market Challenges
 Table 167. Dihydrocodeine Market Restraints
 Table 168. Research Programs/Design for This Report
 Table 169. Key Data Information from Secondary Sources
 Table 170. Key Data Information from Primary Sources
 Table 171. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Dihydrocodeine
 Figure 2. Global Dihydrocodeine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Dihydrocodeine Market Share by Type: 2024 & 2031
 Figure 4. Oral Product Picture
 Figure 5. Injection Product Picture
 Figure 6. Global Dihydrocodeine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Dihydrocodeine Market Share by Application: 2024 & 2031
 Figure 8. Cough Suppressant
 Figure 9. Analgesic
 Figure 10. Global Dihydrocodeine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Dihydrocodeine Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Dihydrocodeine Sales (2020-2031) & (K Units)
 Figure 13. Global Dihydrocodeine Average Price (US$/Unit) & (2020-2031)
 Figure 14. Dihydrocodeine Report Years Considered
 Figure 15. Dihydrocodeine Sales Share by Manufacturers in 2024
 Figure 16. Global Dihydrocodeine Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Dihydrocodeine Players: Market Share by Revenue in Dihydrocodeine in 2024
 Figure 18. Dihydrocodeine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Dihydrocodeine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Dihydrocodeine Sales Market Share by Country (2020-2031)
 Figure 21. North America Dihydrocodeine Revenue Market Share by Country (2020-2031)
 Figure 22. United States Dihydrocodeine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Dihydrocodeine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Dihydrocodeine Sales Market Share by Country (2020-2031)
 Figure 25. Europe Dihydrocodeine Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Dihydrocodeine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Dihydrocodeine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Dihydrocodeine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Dihydrocodeine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Dihydrocodeine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Dihydrocodeine Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Dihydrocodeine Revenue Market Share by Region (2020-2031)
 Figure 33. China Dihydrocodeine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Dihydrocodeine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Dihydrocodeine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Dihydrocodeine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Dihydrocodeine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Dihydrocodeine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Dihydrocodeine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Dihydrocodeine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Dihydrocodeine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Dihydrocodeine Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Dihydrocodeine Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Dihydrocodeine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Dihydrocodeine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Dihydrocodeine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Dihydrocodeine Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Dihydrocodeine Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Dihydrocodeine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Dihydrocodeine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Dihydrocodeine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Dihydrocodeine by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Dihydrocodeine by Type (2020-2031)
 Figure 54. Global Dihydrocodeine Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Dihydrocodeine by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Dihydrocodeine by Application (2020-2031)
 Figure 57. Global Dihydrocodeine Price (US$/Unit) by Application (2020-2031)
 Figure 58. Dihydrocodeine Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String